RN-3161

N/A

Report date: 2025/11/26 20:00:44
NME

Base Information

Drug NameRN-3161
Drug Alias NameRN-3161RN3161
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionInhibin beta E chain modulators
TargetsInhibin beta E chain
Therapy Area/IndicationsOverweightObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDarui Biomedical Technology (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDarui Biomedical Technology (Shanghai) Co LtdIkaria Bioscience Pty Ltd
Inactive CompaniesN/A
Active IndicationsOverweightObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A